TPIDB > Principal Investigator
Principal Investigator
National Taiwan University Hospital
(在職)
Division of General Internal Medicine
Division of Infectious Disease
更新時間:2024-03-26
謝思民Hsieh, Szu-Min
- Principal Investigator
- Clinical Trial Experience (year) 23 years 9 個月
-
doceason1967@gmail.com
Publication
39Publications
31
Chen KH, Liu WD, Sun HY, Lin KY, Hsieh SM, Sheng WH, Hung CC. Immune reconstitution inflammatory syndrome in people living with HIV who presented with interstitial pneumonitis: an emerging challenge in the era of rapid initiation of antiretroviral therapy. Microbiol Spectrum 2023 (DOI: 10.1128/spectrum.04985-22)
32
Chen KH, Sun HY, Chen CH, Chuang YC, Huang YS, Liu WD, Hsieh SM, Sheng WH, Cheng A, Wu TY, Lin KY, Hung CC. Higher Serologic Responses of Early Syphilis to Single-dose Benzathine Penicillin G Plus Doxycycline Versus Single-dose Benzathine Penicillin G Alone Among People With Human Immunodeficiency Virus (HIV). Clin Infect Dis 2024 (DOI: 10.1093/cid/ciad508) https://doi.org/10.1093/cid/ciad508 (Published: 27 August 2023)
33
Guan-Jhou Chen, Hsin-Yun Sun, Sui-Yuan Chang, Szu-Min Hsieh, Wang-Hui Sheng, Yu-Chung Chuang, Yu-Shan Huang, Kuan-Yin Lin, Wen-Chun Liu, Yi-Ching Su, Chien-Ching Hung. Effectiveness of second-generation integrase strand-transfer inhibitor-based regimens for antiretroviral-experienced people with HIV who had viral rebound. J Microbiol Immun Infect 2023; 56: 988-995
34
Kuan-Yin Lin, Hsin-Yun Sun, Yu-Shan Huang, Wang-Da Liu, Szu-Min Hsieh, Sung-Hsi Huang, Guan-Jhou Chen & Chien-Ching Hung. Durability of serologic responses to inactivated hepatitis A virus vaccination among people living with HIV following acute hepatitis A outbreak: a 5-year follow-up study. Emerg Microb Infect 2023; 12 (Online: 31 Jul 2023, https://doi.org/10.1080/22221751.2023.2239946)
35
Sheng WH, Hsieh SM, Chang SC. Achievements of COVID-19 vaccination programs: Taiwanese perspective. J Formos Med Assoc 2024; 123: 570-576 (https://doi.org/10.1016/j.jfma.2023.04.017).
36
Liu WD, Meng-Shuan Lin, Hsin-Yun Sun, Ming-Chieh Shih, Yu-Chung Chuang, Yu-Shan Huang, Kuan-Yin Lin, Guei-Chi Li, Pei-Ying Wu, Ling-Ya Chen, Wen-Chun Liu, Yi-Ching Su, Pu-Chi He, Yi-Ting Chen, Chia-Yi Lin, Yu-Chen Cheng, Yi Yao, Yi-Chen Yeh, Chia-Chi Liu, Mei-Yan Pan, Yu-Zhen Luo, Hsi-Yen Chang, Jann-Tay Wang, Wang-Huei Sheng, Szu-Min Hsieh, Sui-Yuan Chang, Chien-Ching Hung. Effectiveness and evolution of anti-SARS-CoV-2 spike protein titers after three doses of COVID-19 vaccination in people with HIV. J Microbiol Immunol Infect. 26 Feb 2024, https://doi.org/10.1016/j.jmii.2024.02.004
37
Huang YS, Hsieh SM, Tsai FC, et al. Serological Responses to COVID-19 Vaccination in Patients with Chronic Liver Diseases. J Formos Med Assoc 2024 (available online 21 June 2024) (https://doi.org/10.1016/j.jfma.2024.06.015)
38
Huang YS, Sun HY, Ho SY, Lin KY, Liu WD, Hsieh SM, Hung CC. Incidence and outcome of hepatitis D virus infection in people with HIV and HBV coinfection in the era of tenofovir-containing antiretroviral therapy. Clin Infect Dis 2025 (DOI: 10.1093/cid/ciae655)
39
Liu WD, Chao TL, Chen Kai-Hsiang, Sun HY, Lin KY, Hsieh SM, Hung CC. Short-term evolution of Mpox-specific IgG and neutralizing antibiodies among individuals undergoing MVA-BN vaccination. Available online 31 Jan 2025 (107830) Intern J Infect Dis 2025